Didik Tulus Subekti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Didik Tulus Subekti has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Fitrine Ekawasti
Research Center for Veterinary Research, National Research and Innovation Agency of the Republic of Indonesia, Cibinong, West Java 16912, Indonesia, Indonesia
5 shared publications - Muhammad Ibrahim Desem
Indonesian Research Center for Veterinary Science
4 shared publications - Mira Fatmawati
Veterinary Public Health Laboratory, Faculty of Veterinary Medicine, Universitas Brawijaya
3 shared publications Mufasirin Mufasirin
Division of Parasitology, Faculty of Veterinary Medicine, Airlangga University, Surabaya, East Java 60115, Indonesia
3 shared publications- Sulinawati Fong
Balai Veteriner Lampung
3 shared publications Sunarno Sunarno
Center for Biomedical Research, National Research and Innovation Agency, Cibinong Science Center, Bogor, West Jawa 16911, Indonesia
3 shared publications
Latest Publications
- Open Access
- 27 April 2026
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 10 (2) , 025380407
Comparative analysis of diagnostic methods for high-risk HPV detection: A scoping review and meta-analysis
Introduction: High-risk (HR) human papillomavirus (HPV) is the main cause of cervical cancer and a substantial proportion of oropharyngeal cancers, making early and accurate detection critical for effective screening and prevention, particularly in low-resource settings. Objective: This study aims to compare the diagnostic accuracy of point-of-care and rapid testing methods for HR-HPV detection. Methods: We conducted a scoping review and meta-analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews framework. PubMed/MEDLINE, ScienceDirect, and Scopus were searched for English-language studies published from 2010 through July 2025. Fifteen studies met the inclusion criteria, with eight included in the meta-analysis. Results: Recombinase polymerase amplification combined with clustered regularly interspaced short palindromic repeats/Cas12a achieved the highest pooled diagnostic performance, with a sensitivity of 0.94 and specificity of 0.97. Polymerase chain reaction-based analyses also showed high accuracy (sensitivity = 0.85; specificity = 0.97) but exhibited considerable heterogeneity across platforms and sample types. Loop-mediated isothermal amplification demonstrated moderate performance (sensitivity = 0.60; specificity = 0.91), while p16 immunohistochemistry offered good sensitivity (0.91) but lower specificity (0.73), supporting its use as a confirmatory rather than primary screening tool. In situ hybridization and next-generation sequencing provided broader genotyping capability but were limited by higher cost and technical complexity. Conclusion: Polymerase chain reaction remains the clinical gold standard for HR-HPV detection, whereas recombinase polymerase amplification/clustered regularly interspaced short palindromic repeats–Cas12a emerges as a promising alternative for decentralized, low-resource screening. Future multi-center studies should standardize reporting, expand genotype coverage beyond HPV-16 and HPV-18, and assess cost, turnaround time, and operational feasibility to ensure that advances in HR-HPV diagnostics translate effectively into public health benefit.
- 27 April 2026
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 10 (2) , 025380407
Open AccessComparative analysis of diagnostic methods for high-risk HPV detection: A scoping review and meta-analysis
Introduction: High-risk (HR) human papillomavirus (HPV) is the main cause of cervical cancer and a substantial proportion of oropharyngeal cancers, making early and accurate detection critical for effective screening and prevention, particularly in low-resource settings. Objective: This study aims to compare the diagnostic accuracy of point-of-care and rapid testing methods for HR-HPV detection. Methods: We conducted a scoping review and meta-analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews framework. PubMed/MEDLINE, ScienceDirect, and Scopus were searched for English-language studies published from 2010 through July 2025. Fifteen studies met the inclusion criteria, with eight included in the meta-analysis. Results: Recombinase polymerase amplification combined with clustered regularly interspaced short palindromic repeats/Cas12a achieved the highest pooled diagnostic performance, with a sensitivity of 0.94 and specificity of 0.97. Polymerase chain reaction-based analyses also showed high accuracy (sensitivity = 0.85; specificity = 0.97) but exhibited considerable heterogeneity across platforms and sample types. Loop-mediated isothermal amplification demonstrated moderate performance (sensitivity = 0.60; specificity = 0.91), while p16 immunohistochemistry offered good sensitivity (0.91) but lower specificity (0.73), supporting its use as a confirmatory rather than primary screening tool. In situ hybridization and next-generation sequencing provided broader genotyping capability but were limited by higher cost and technical complexity. Conclusion: Polymerase chain reaction remains the clinical gold standard for HR-HPV detection, whereas recombinase polymerase amplification/clustered regularly interspaced short palindromic repeats–Cas12a emerges as a promising alternative for decentralized, low-resource screening. Future multi-center studies should standardize reporting, expand genotype coverage beyond HPV-16 and HPV-18, and assess cost, turnaround time, and operational feasibility to ensure that advances in HR-HPV diagnostics translate effectively into public health benefit.
- 30 January 2025
- Published by Elsevier in The Veterinary Journal
- Vol. 310, 106306
Nucleic acid amplification–lateral flow immunoassay (NAA-LFIA) for the rapid differentiation of Trypanosoma evansi and Trypanosoma equiperdum
- 30 January 2025
- Published by Elsevier in The Veterinary Journal
- Vol. 310, 106306
Nucleic acid amplification–lateral flow immunoassay (NAA-LFIA) for the rapid differentiation of Trypanosoma evansi and Trypanosoma equiperdum
- 15 June 2024
- Published by Elsevier in Veterinary Parasitology
- Vol. 330, 110236
Molecular characterization of trypanocide-resistant strains derived from a single field isolate of Trypanosoma evansi
- 15 June 2024
- Published by Elsevier in Veterinary Parasitology
- Vol. 330, 110236
Molecular characterization of trypanocide-resistant strains derived from a single field isolate of Trypanosoma evansi
- Open Access
High-Performance, Easy-to-Fabricate, Nanocomposite Heater for Life Sciences and Biomedical Applications
Microheaters are used in several applications, including medical diagnostics, synthesis, environmental monitoring, and actuation. Conventional microheaters rely on thin-film electrodes microfabricated in a clean-room environment. However, low-cost alternatives based on conductive paste electrodes fabricated using printing techniques have started to emerge over the years. Here, we report a surprising effect that leads to significant electrode performance improvement as confirmed by the thorough characterization of bulk, processed, and conditioned samples. Mixing silver ink and PVA results in the solubilization of performance-hindering organic compounds. These compounds evaporate during heating cycles. The new electrodes, which reach a temperature of 80 °C within 5 min using a current of 7.0 A, display an overall 42% and 35% improvement in the mechanical (hardness) and electrical (resistivity) properties compared to pristine silver ink electrodes. To validate our results, we use the composite heater to amplify and detect parasite DNA from Trypanosoma brucei, associated with African sleeping sickness. Our LAMP test compares well with commercially available systems, confirming the excellent performance of our nanocomposite heaters. Since their fabrication relies on well-established techniques, we anticipate they will find use in a range of applications.
Open AccessHigh-Performance, Easy-to-Fabricate, Nanocomposite Heater for Life Sciences and Biomedical Applications
Microheaters are used in several applications, including medical diagnostics, synthesis, environmental monitoring, and actuation. Conventional microheaters rely on thin-film electrodes microfabricated in a clean-room environment. However, low-cost alternatives based on conductive paste electrodes fabricated using printing techniques have started to emerge over the years. Here, we report a surprising effect that leads to significant electrode performance improvement as confirmed by the thorough characterization of bulk, processed, and conditioned samples. Mixing silver ink and PVA results in the solubilization of performance-hindering organic compounds. These compounds evaporate during heating cycles. The new electrodes, which reach a temperature of 80 °C within 5 min using a current of 7.0 A, display an overall 42% and 35% improvement in the mechanical (hardness) and electrical (resistivity) properties compared to pristine silver ink electrodes. To validate our results, we use the composite heater to amplify and detect parasite DNA from Trypanosoma brucei, associated with African sleeping sickness. Our LAMP test compares well with commercially available systems, confirming the excellent performance of our nanocomposite heaters. Since their fabrication relies on well-established techniques, we anticipate they will find use in a range of applications.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Parasitologia Veterinária
- Vol. 33 (2) , e001324
Molecular identification of new Trypanosoma evansi type non-A/B isolates from buffaloes and cattle in Indonesia
Trypanosoma evansi is reportedly divided into two genotypes: types A and B. The type B is uncommon and reportedly limited to Africa: Kenya Sudan, and Ethiopia. In contrast, type A has been widely reported in Africa, South America, and Asia. However, Trypanosoma evansi type non-A/B has never been reported. Therefore, this study aims to determine the species and genotype of the Trypanozoon subgenus using a robust identification algorithm. Forty-three trypanosoma isolates from Indonesia were identified as Trypanosoma evansi using a molecular identification algorithm. Further identification showed that 39 isolates were type A and 4 isolates were possibly non-A/B types. The PML, AMN-SB1, and STENT3 isolates were likely non-A/B type Trypanosoma evansi isolated from buffalo, while the PDE isolates were isolated from cattle. Cladistic analysis revealed that Indonesian Trypanosoma evansi was divided into seven clusters based on the gRNA-kDNA minicircle gene. Clusters 6 and 7 are each divided into two sub-clusters. The areas with the highest genetic diversity are the provinces of Banten, Central Java (included Yogyakarta), and East Nusa Tenggara. The Central Java (including Yogyakarta) and East Nusa Tenggara provinces, each have four sub-clusters, while Banten has three.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Parasitologia Veterinária
- Vol. 33 (2) , e001324
Open AccessMolecular identification of new Trypanosoma evansi type non-A/B isolates from buffaloes and cattle in Indonesia
Trypanosoma evansi is reportedly divided into two genotypes: types A and B. The type B is uncommon and reportedly limited to Africa: Kenya Sudan, and Ethiopia. In contrast, type A has been widely reported in Africa, South America, and Asia. However, Trypanosoma evansi type non-A/B has never been reported. Therefore, this study aims to determine the species and genotype of the Trypanozoon subgenus using a robust identification algorithm. Forty-three trypanosoma isolates from Indonesia were identified as Trypanosoma evansi using a molecular identification algorithm. Further identification showed that 39 isolates were type A and 4 isolates were possibly non-A/B types. The PML, AMN-SB1, and STENT3 isolates were likely non-A/B type Trypanosoma evansi isolated from buffalo, while the PDE isolates were isolated from cattle. Cladistic analysis revealed that Indonesian Trypanosoma evansi was divided into seven clusters based on the gRNA-kDNA minicircle gene. Clusters 6 and 7 are each divided into two sub-clusters. The areas with the highest genetic diversity are the provinces of Banten, Central Java (included Yogyakarta), and East Nusa Tenggara. The Central Java (including Yogyakarta) and East Nusa Tenggara provinces, each have four sub-clusters, while Banten has three.
- Open Access
- 25 December 2023
- Published by Veterinary World in Veterinary World
- Vol. 16 (12) , 2479-2487
Molecular analysis and geographic distribution of the recent Indonesian rabies virus
Background and Aim: Some Indonesian islands, including Sumatra, Kalimantan, Sulawesi, Java, and East Nusa Tenggara, have endemic rabies. Rabies outbreaks in Bali began from 2008 to 2011 and continue to occur sporadically. This study aimed to study the molecular analysis and geographical distribution of Indonesian rabies virus (RABV) from 2016 to 2021 and compare to previous periods. Materials and Methods: Virus isolates from 2016 to 2021 were extracted from dog brains and sequenced at the nucleoprotein gene locus. They were compared with data sequences available in the GenBank database. Indonesian RABV from the previous three periods (before 1989, 1997–2003, and 2008–2010) was extracted from the GenBank database. The genetic diversity in this study was based on the N gene of Indonesian RABV. Results: Asian RABV, which is genetically close to the Indonesian virus, is a virus from China (ASIA-3 cluster) and from the Southeast Asia region, namely, virus isolates from Sarawak and Malaysia and some Cambodian isolates. Rabies virus, which was isolated from the Bali islands, was the new cluster first detected and published in Bali, Indonesia, in 2008, while RABV from West Sumatra Province, which was isolated from 2016 to 2021, was also considered a new cluster that is genetically distant from other clusters in Indonesia. Conclusion: The RABV in Indonesia is divided into five clusters. The isolates from West Sumatra Province from 2016 to 2021 were a new cluster genetically distant from other Indonesian viruses. Keywords: genetic diversity, geographical distribution, nucleoprotein gene, rabies.
- 25 December 2023
- Published by Veterinary World in Veterinary World
- Vol. 16 (12) , 2479-2487
Open AccessMolecular analysis and geographic distribution of the recent Indonesian rabies virus
Background and Aim: Some Indonesian islands, including Sumatra, Kalimantan, Sulawesi, Java, and East Nusa Tenggara, have endemic rabies. Rabies outbreaks in Bali began from 2008 to 2011 and continue to occur sporadically. This study aimed to study the molecular analysis and geographical distribution of Indonesian rabies virus (RABV) from 2016 to 2021 and compare to previous periods. Materials and Methods: Virus isolates from 2016 to 2021 were extracted from dog brains and sequenced at the nucleoprotein gene locus. They were compared with data sequences available in the GenBank database. Indonesian RABV from the previous three periods (before 1989, 1997–2003, and 2008–2010) was extracted from the GenBank database. The genetic diversity in this study was based on the N gene of Indonesian RABV. Results: Asian RABV, which is genetically close to the Indonesian virus, is a virus from China (ASIA-3 cluster) and from the Southeast Asia region, namely, virus isolates from Sarawak and Malaysia and some Cambodian isolates. Rabies virus, which was isolated from the Bali islands, was the new cluster first detected and published in Bali, Indonesia, in 2008, while RABV from West Sumatra Province, which was isolated from 2016 to 2021, was also considered a new cluster that is genetically distant from other clusters in Indonesia. Conclusion: The RABV in Indonesia is divided into five clusters. The isolates from West Sumatra Province from 2016 to 2021 were a new cluster genetically distant from other Indonesian viruses. Keywords: genetic diversity, geographical distribution, nucleoprotein gene, rabies.
- Open Access
- 16 November 2023
- Published by UNS Solo in Biodiversitas Journal of Biological Diversity
- Vol. 24 (11)
Optimization of deoxyribonucleic acid extraction and polymerase chain reaction methods for gene detection of Toxoplasma gondii in goat milk
Fatmawati M, Suwanti LT, Mufasirin, Subekti DT, Ekawasti F, Lastuti NDR, Lamid M, Suprihati E, Effendi MH, Al-Arif A. 2023. Optimization of deoxyribonucleic acid extraction and polymerase chain reaction methods for gene detection of Toxoplasma gondii in goat milk. Biodiversitas 24: 5905-5911. Dairy goats (Capra aegagrus hircus) are intermediate hosts that transmit Toxoplasma gondii to humans through goat milk consumption. T. gondii can invade mammary glands and secrete into milk. The method of detecting gene of the T. gondii in milk is through a Polymerase Chain Reaction (PCR) test based on specific genes. The objective of this study was to compare the efficacy methods of the T. gondii molecular assay from the extraction, master mix for PCR assay, and primer that is possible to amplify the gene of T. gondii in goat milk for PCR assay. The research method for purification used flotation using concentrated sugar. This research compared the extraction kit from Kit Extraction 1 (K1), Kit Extraction 2 (K2), and Kit Extraction 3 (K3) with the extraction method listed in the brochure. Meanwhile, for the PCR assay, three types of master mix were used, including Master Mix 1 (M1), Master Mix 2 (M2), and Master Mix 3 (M3). The specific genes used included primers B1, ROP, GRA 1, GRA 7, BAG 1, and P30. Tris borate EDTA (TBE) or Phosphate Buffer Saline Solution (PBS) as buffer milk samples gave the same PCR test results. The results show that the principle of a flotation method test using PBS can be used to prepare the milk sample. The research showed that extraction kit 1 (K1) and extraction kit 2 (K2) gave positive results for the positive control. However, in terms of price, K2 is cheaper than K1. So, to optimize DNA extraction, K2 can be used. The master mix that can be used for PCR testing of milk samples is M1 because M1 gives positive results for positive controls and negative results for negative controls. Primers for optimal results used GRA 7 and B1 with denaturation temperature of 94°C, annealing at 56°C, and an extension of 73°C 33. This research concluded that the type of DNA extraction kit affects the PCR test results for detecting T. gondii in goat milk. It is necessary to optimize the type of master mix to be used in PCR testing and primers capable of amplifying the T. gondii gene.
- 16 November 2023
- Published by UNS Solo in Biodiversitas Journal of Biological Diversity
- Vol. 24 (11)
Open AccessOptimization of deoxyribonucleic acid extraction and polymerase chain reaction methods for gene detection of Toxoplasma gondii in goat milk
Fatmawati M, Suwanti LT, Mufasirin, Subekti DT, Ekawasti F, Lastuti NDR, Lamid M, Suprihati E, Effendi MH, Al-Arif A. 2023. Optimization of deoxyribonucleic acid extraction and polymerase chain reaction methods for gene detection of Toxoplasma gondii in goat milk. Biodiversitas 24: 5905-5911. Dairy goats (Capra aegagrus hircus) are intermediate hosts that transmit Toxoplasma gondii to humans through goat milk consumption. T. gondii can invade mammary glands and secrete into milk. The method of detecting gene of the T. gondii in milk is through a Polymerase Chain Reaction (PCR) test based on specific genes. The objective of this study was to compare the efficacy methods of the T. gondii molecular assay from the extraction, master mix for PCR assay, and primer that is possible to amplify the gene of T. gondii in goat milk for PCR assay. The research method for purification used flotation using concentrated sugar. This research compared the extraction kit from Kit Extraction 1 (K1), Kit Extraction 2 (K2), and Kit Extraction 3 (K3) with the extraction method listed in the brochure. Meanwhile, for the PCR assay, three types of master mix were used, including Master Mix 1 (M1), Master Mix 2 (M2), and Master Mix 3 (M3). The specific genes used included primers B1, ROP, GRA 1, GRA 7, BAG 1, and P30. Tris borate EDTA (TBE) or Phosphate Buffer Saline Solution (PBS) as buffer milk samples gave the same PCR test results. The results show that the principle of a flotation method test using PBS can be used to prepare the milk sample. The research showed that extraction kit 1 (K1) and extraction kit 2 (K2) gave positive results for the positive control. However, in terms of price, K2 is cheaper than K1. So, to optimize DNA extraction, K2 can be used. The master mix that can be used for PCR testing of milk samples is M1 because M1 gives positive results for positive controls and negative results for negative controls. Primers for optimal results used GRA 7 and B1 with denaturation temperature of 94°C, annealing at 56°C, and an extension of 73°C 33. This research concluded that the type of DNA extraction kit affects the PCR test results for detecting T. gondii in goat milk. It is necessary to optimize the type of master mix to be used in PCR testing and primers capable of amplifying the T. gondii gene.
- Open Access
- 23 September 2023
- Published by Veterinary World in Veterinary World
- Vol. 16 (9) , 1926-1932
Serological survey of immunoglobulin G from Toxoplasma gondii infection in dairy goats in East Java, Indonesia
Background and Aim: Toxoplasma gondii infection is a significant issue of veterinary public health because it is potentially transmitted through goat milk. Therefore, the use of control measures and routine monitoring of toxoplasmosis in dairy goats is necessary. Serological analysis using antibodies can detect T. gondii infection. This study aimed to conduct an epidemiological study of T. gondii in dairy goats using antibody detection and risk factor identification. Materials and Methods: This was a cross-sectional study. We performed a serological analysis of T. gondii infection in dairy goats to evaluate the prevalence of toxoplasmosis. Random sampling was performed, including 132 lactating dairy goats. Toxoplasma-modified agglutination test was used as a serological test for immunoglobulin G with a sensitivity of 98.55%, specificity of 86.21%, and accuracy of 94.9%. A structured questionnaire was used to collect risk factor data, which were analyzed using the Chi-square and Fisher's exact tests. The statistical package for the social sciences v. 21 was used for statistical analyses. Results: The seroprevalence of T. gondii in Malang and Lumajang Regency was 100% and 90.7%, respectively. A significant difference in prevalence of T. gondii was observed between the two districts. Livestock management practices that significantly influenced T. gondii seroprevalence included water sources (p < 0.05; relative risk [RR] = 1.151; 95% confidence interval [CI]: 1.044-1.269). Farmers’ characteristics that significantly influenced T. gondii seroprevalence included education (p < 0.05; RR = 1.125; 95% CI: 1.037-1.221), main occupation (p < 0.05; RR = 1.118; 95% CI: 1.035- 1.207), and position in the organization of dairy goats farmers (p < 0.05; RR = 1.141; 95% CI: 1.022-1.274). Conclusion: In East Java, the prevalence of T. gondii in dairy goats is high. This study provides detailed information regarding risk factors associated with T. gondii seroprevalence in dairy goats in East Java, Indonesia. Keywords: dairy goats, risk factor, seroprevalence, toxoplasma modified agglutination test.
- 23 September 2023
- Published by Veterinary World in Veterinary World
- Vol. 16 (9) , 1926-1932
Open AccessSerological survey of immunoglobulin G from Toxoplasma gondii infection in dairy goats in East Java, Indonesia
Background and Aim: Toxoplasma gondii infection is a significant issue of veterinary public health because it is potentially transmitted through goat milk. Therefore, the use of control measures and routine monitoring of toxoplasmosis in dairy goats is necessary. Serological analysis using antibodies can detect T. gondii infection. This study aimed to conduct an epidemiological study of T. gondii in dairy goats using antibody detection and risk factor identification. Materials and Methods: This was a cross-sectional study. We performed a serological analysis of T. gondii infection in dairy goats to evaluate the prevalence of toxoplasmosis. Random sampling was performed, including 132 lactating dairy goats. Toxoplasma-modified agglutination test was used as a serological test for immunoglobulin G with a sensitivity of 98.55%, specificity of 86.21%, and accuracy of 94.9%. A structured questionnaire was used to collect risk factor data, which were analyzed using the Chi-square and Fisher's exact tests. The statistical package for the social sciences v. 21 was used for statistical analyses. Results: The seroprevalence of T. gondii in Malang and Lumajang Regency was 100% and 90.7%, respectively. A significant difference in prevalence of T. gondii was observed between the two districts. Livestock management practices that significantly influenced T. gondii seroprevalence included water sources (p < 0.05; relative risk [RR] = 1.151; 95% confidence interval [CI]: 1.044-1.269). Farmers’ characteristics that significantly influenced T. gondii seroprevalence included education (p < 0.05; RR = 1.125; 95% CI: 1.037-1.221), main occupation (p < 0.05; RR = 1.118; 95% CI: 1.035- 1.207), and position in the organization of dairy goats farmers (p < 0.05; RR = 1.141; 95% CI: 1.022-1.274). Conclusion: In East Java, the prevalence of T. gondii in dairy goats is high. This study provides detailed information regarding risk factors associated with T. gondii seroprevalence in dairy goats in East Java, Indonesia. Keywords: dairy goats, risk factor, seroprevalence, toxoplasma modified agglutination test.
- 1 July 2023
- Published by American Society of Parasitologists in Journal of Parasitology
- Vol. 109 (4) , 436-444
DOES TRYPANOSOMA EVANSI HAVE THE MAXICIRCLE GENE, OR CAN TRYPANOSOMA EQUIPERDUM BE ISOLATED FROM BOVINES?
Identifying a trypanosome isolate is generally based on morphological observations and molecular identification of one of the genes, usually internal transcribed spacer 1 and 2 of ribosomal DNA (ITS1 rDNA, ITS2 rDNA), a variant surface glycoprotein of Rode Trypanozoon antigen type 1.2 (VSG RoTat 1.2), or expression site-associated genes (ESAG). However, this identification is insufficient because these genes cannot distinguish organisms in the subgenus Trypanozoon to the species level. A molecular approach using at least 5 sets of primers is needed, namely, ITS1, ESAG6/7, MINI, RoTat 1.2, and ND5, for stratified selection to obtain more targeted and conclusive results. Using this method to analyze isolates from Indonesia provided unexpected results: 9 isolates previously identified as Trypanozoon were found to have the kDNA maxicircle gene. Nine isolates of Trypanosoma equiperdum were identified for the first time in Indonesia, isolated from bovine (cattle and buffaloes). The identification of T. equiperdum in the 9 isolates was confirmed by analysis of the nucleotide sequence identity of the nad5-kDNA maxicircle gene.
- 1 July 2023
- Published by American Society of Parasitologists in Journal of Parasitology
- Vol. 109 (4) , 436-444
DOES TRYPANOSOMA EVANSI HAVE THE MAXICIRCLE GENE, OR CAN TRYPANOSOMA EQUIPERDUM BE ISOLATED FROM BOVINES?
Identifying a trypanosome isolate is generally based on morphological observations and molecular identification of one of the genes, usually internal transcribed spacer 1 and 2 of ribosomal DNA (ITS1 rDNA, ITS2 rDNA), a variant surface glycoprotein of Rode Trypanozoon antigen type 1.2 (VSG RoTat 1.2), or expression site-associated genes (ESAG). However, this identification is insufficient because these genes cannot distinguish organisms in the subgenus Trypanozoon to the species level. A molecular approach using at least 5 sets of primers is needed, namely, ITS1, ESAG6/7, MINI, RoTat 1.2, and ND5, for stratified selection to obtain more targeted and conclusive results. Using this method to analyze isolates from Indonesia provided unexpected results: 9 isolates previously identified as Trypanozoon were found to have the kDNA maxicircle gene. Nine isolates of Trypanosoma equiperdum were identified for the first time in Indonesia, isolated from bovine (cattle and buffaloes). The identification of T. equiperdum in the 9 isolates was confirmed by analysis of the nucleotide sequence identity of the nad5-kDNA maxicircle gene.
- Open Access
- 25 January 2023
- Published by Wiley in Veterinary Medicine International
- Vol. 2023 (1) , 4096258
Evaluation of In‐House ELISA for Antirabies Antibodies Detection in Domestic Canine
Indonesia is known to be endemic for rabies in several areas, especially in Sumatra, Kalimantan, Sulawesi, and Flores Islands. Currently, vaccinating dogs has been shown to be the most cost‐effective strategy for preventing rabies in humans. Postvaccination monitoring should be carried out to evaluate the success of vaccination by measuring antibody titers in serum of vaccinated dogs. Serological methods for monitoring rabies‐specific antibody titers can be carried out using enzyme‐linked immunosorbent assay (ELISA) methods as recommended by the World Organization for Animal Health (WOAH). Therefore, the development of the in‐house ELISA (BukTi‐Vet) that we have carried out in order to support postvaccination monitoring in dogs needs to be evaluated for its diagnostic performance compared to commercial ELISA kits. The diagnostic performance of each ELISA kit was evaluated using 111 known positive and 47 negative serums. Each known positive and negative serum will be tested using the three rabies ELISA kits used in this study. BukTi‐Vet is an in‐house ELISA for the detection of rabies‐specific IgG antibodies that have been developed with sensitivity, specificity, and accuracy of 98.19%, 97.87%, and 98.1%, respectively. Based on the value of its positive and negative clinical utility index, BukTi‐Vet is excellent for use in immunoassays directed for confirmatory (0.97) as well as screening (0.94) tests. BukTi‐Vet shows a very good agreement with both Platelia II and RFFIT, so it is convincing to be further refined into a diagnostic kit. Tests of field sera from dogs vaccinated with various vaccines should be performed to provide more complete information on diagnostic performance. BukTi‐Vet showed a very good agreement with RFFIT, while Pusvetma and Platelia II only showed good agreement. The average value of BukTi‐Vet compatibility with RFFIT can reach 94%.
- 25 January 2023
- Published by Wiley in Veterinary Medicine International
- Vol. 2023 (1) , 4096258
Open AccessEvaluation of In‐House ELISA for Antirabies Antibodies Detection in Domestic Canine
Indonesia is known to be endemic for rabies in several areas, especially in Sumatra, Kalimantan, Sulawesi, and Flores Islands. Currently, vaccinating dogs has been shown to be the most cost‐effective strategy for preventing rabies in humans. Postvaccination monitoring should be carried out to evaluate the success of vaccination by measuring antibody titers in serum of vaccinated dogs. Serological methods for monitoring rabies‐specific antibody titers can be carried out using enzyme‐linked immunosorbent assay (ELISA) methods as recommended by the World Organization for Animal Health (WOAH). Therefore, the development of the in‐house ELISA (BukTi‐Vet) that we have carried out in order to support postvaccination monitoring in dogs needs to be evaluated for its diagnostic performance compared to commercial ELISA kits. The diagnostic performance of each ELISA kit was evaluated using 111 known positive and 47 negative serums. Each known positive and negative serum will be tested using the three rabies ELISA kits used in this study. BukTi‐Vet is an in‐house ELISA for the detection of rabies‐specific IgG antibodies that have been developed with sensitivity, specificity, and accuracy of 98.19%, 97.87%, and 98.1%, respectively. Based on the value of its positive and negative clinical utility index, BukTi‐Vet is excellent for use in immunoassays directed for confirmatory (0.97) as well as screening (0.94) tests. BukTi‐Vet shows a very good agreement with both Platelia II and RFFIT, so it is convincing to be further refined into a diagnostic kit. Tests of field sera from dogs vaccinated with various vaccines should be performed to provide more complete information on diagnostic performance. BukTi‐Vet showed a very good agreement with RFFIT, while Pusvetma and Platelia II only showed good agreement. The average value of BukTi‐Vet compatibility with RFFIT can reach 94%.